Correlation Between Lisata Therapeutics and Imunon
Can any of the company-specific risk be diversified away by investing in both Lisata Therapeutics and Imunon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lisata Therapeutics and Imunon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lisata Therapeutics and Imunon Inc, you can compare the effects of market volatilities on Lisata Therapeutics and Imunon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lisata Therapeutics with a short position of Imunon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lisata Therapeutics and Imunon.
Diversification Opportunities for Lisata Therapeutics and Imunon
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lisata and Imunon is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Lisata Therapeutics and Imunon Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imunon Inc and Lisata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lisata Therapeutics are associated (or correlated) with Imunon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imunon Inc has no effect on the direction of Lisata Therapeutics i.e., Lisata Therapeutics and Imunon go up and down completely randomly.
Pair Corralation between Lisata Therapeutics and Imunon
Given the investment horizon of 90 days Lisata Therapeutics is expected to generate 0.86 times more return on investment than Imunon. However, Lisata Therapeutics is 1.17 times less risky than Imunon. It trades about 0.02 of its potential returns per unit of risk. Imunon Inc is currently generating about -0.1 per unit of risk. If you would invest 241.00 in Lisata Therapeutics on July 17, 2025 and sell it today you would earn a total of 2.00 from holding Lisata Therapeutics or generate 0.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lisata Therapeutics vs. Imunon Inc
Performance |
| Timeline |
| Lisata Therapeutics |
| Imunon Inc |
Lisata Therapeutics and Imunon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lisata Therapeutics and Imunon
The main advantage of trading using opposite Lisata Therapeutics and Imunon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lisata Therapeutics position performs unexpectedly, Imunon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will offset losses from the drop in Imunon's long position.| Lisata Therapeutics vs. Theriva Biologics | Lisata Therapeutics vs. CervoMed | Lisata Therapeutics vs. Avalo Therapeutics | Lisata Therapeutics vs. Gyre Therapeutics |
| Imunon vs. SAB Biotherapeutics | Imunon vs. Theriva Biologics | Imunon vs. Lisata Therapeutics | Imunon vs. Quince Therapeutics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |